Dr DERYCKERE Francois

Fiche personne

Coordonnées

UMR7242 Biotechnologie et Signalisation Cellulaire - ESBS
300 bd Sébastien Brant
CS 10413
67412 ILLKIRCH Cedex

+33 3 90 24 47 63

Territoire

Alsace

Statut

Enseignant-Chercheur

Affiliation

Ecole Supérieure de Biotechnologie de Strasbourg / Biotechnologie et signalisation cellulaire (ESBS-BSC)

Université de Strasbourg (Unistra)

Projets

Restauration de la voie p53 dans les cellules cancéreuses HPV à l’aide d’adénovirus recombinants

2012 - Porteur du projet : Dr DERYCKERE Francois

Publications

Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.

Freyermuth F, Rau F, Kokunai Y, Linke T, Sellier C, Nakamori M, Kino Y, Arandel L, Jollet A, Thibault C, Philipps M, Vicaire S, Jost B, Udd B, Day JW, Duboc D, Wahbi K, Matsumura T, Fujimura H, Mochizuki H, Deryckere F, Kimura T, Nukina N, Ishiura S, Lacroix V, Campan-Fournier A, Navratil V, Chautard E, Auboeuf D, Horie M, Imoto K, Lee KY, Swanson MS, Lopez de Munain A, Inada S, Itoh H, Nakazawa K, Ashihara T, Wang E, Zimmer T, Furling D, Takahashi MP, Charlet-Berguerand N

Nat Commun. 2016 Apr;7:11067

Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.

Bonetta AC, Mailly L, Robinet E, Trave G, Masson M, Deryckere F

Biochem Biophys Res Commun. 2015 Aug 1. pii: S0006-291X(15)30375-2

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.

Ramirez J, Poirson J, Foltz C, Chebaro Y, Schrapp M, Meyer A, Bonetta A, Forster A, Jacob Y, Masson M, Deryckere F, Trave G

Angew Chem Int Ed Engl. 2015 May 27

Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential.

El-Andaloussi N, Bonifati S, Kaufmann JK, Mailly L, Daeffler L, Deryckere F, Nettelbeck DM, Rommelaere J, Marchini A

J Virol. 2012 Oct;86(19):10418-31

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.

Fugier C, Klein AF, Hammer C, Vassilopoulos S, Ivarsson Y, Toussaint A, Tosch V, Vignaud A, Ferry A, Messaddeq N, Kokunai Y, Tsuburaya R, de la Grange P, Dembele D, Francois V, Precigout G, Boulade-Ladame C, Hummel MC, de Munain AL, Sergeant N, Laquerriere A, Thibault C, Deryckere F, Auboeuf D, Garcia L, Zimmermann P, Udd B, Schoser B, Takahashi MP, Nishino I, Bassez G, Laporte J, Furling D, Charlet-Berguerand N

Nat Med. 2011 Jun;17(6):720-5

Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain.

Bernard X, Robinson P, Nomine Y, Masson M, Charbonnier S, Ramirez-Ramos JR, Deryckere F, Trave G, Orfanoudakis G

PLoS One. 2011;6(10):e25981

Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis.

Van Doorslaer K, Sidi AO, Zanier K, Rybin V, Deryckere F, Rector A, Burk RD, Lienau EK, van Ranst M, Trave G

J Virol. 2009 Sep;83(17):8759-70

A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter.

Mailly L, Boulade-Ladame C, Orfanoudakis G, Deryckere F

Virol J. 2008 Jun 6;5:73.

Modification of adenovirus type 5 tropism for a preferential transduction of human papillomavirus-positive cancer cells.

Lagrange M, Boulade-Ladame C, Orfanoudakis G, Deryckere F

Arch Virol. 2008;153(10):1921-5

Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells.

Lagrange M, Boulade-Ladame C, Mailly L, Weiss E, Orfanoudakis G, Deryckere F

Biochem Biophys Res Commun. 2007 Sep 21;361(2):487-92

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

Nomine Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckere F, Sibler AP, Desplancq D, Atkinson RA, Weiss E, Orfanoudakis G, Kieffer B, Trave G

Mol Cell. 2006 Mar 3;21(5):665-78.